CSPG4 and neoplasm: Among the 26 RCC cases, the PD-L1-positive rate in tumor cells was higher in samples with the 4 somatically mutated genes, including CSPG4, DNAH11, INADL and TMPRSS13, than in samples without those (P > 0.05).